MedTrace Logo

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

NCT03560440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 368

Last updated 2018-06-18

No results posted yet for this study

Summary

In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine.

Conditions

  • Gram-Positive Bacterial Infections

Interventions

OTHER

Plasma exposure vancomycin

Investigation of plasma exposure of vancomycin.

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Isabel Spriet, PharmD PhD · UZ Leuven

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-02-29
Completion
2017-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03560440 on ClinicalTrials.gov